Skip to main content

Have you heard about our new siliconization operation?

We are pleased to announce the opening of a siliconization line at our state-of-the-art Saint-Quentin Lamotte (SQLM) plant, which safeguards the integrity of sensitive, aggressive and viscous drug products.


What is siliconization?

A micro layer of silicone is highly bonded to the internal surface of the glass vial. The optimized process ensures meticulous injection monitoring to deliver uniform coverage, dose repeatability and precise quantities. The process is executed with rigorous quality control under an ISO 8 clean room, in an ISO 15378 certified facility.



 Why add siliconization to your vials?

The silicone coating provides a protective layer between the vial and therapeutic product inside, resulting in key benefits for a wide variety of market applications including: anti-infectives, parenteral nutrition, diagnostics, animal health and oncology.

SGD Pharma’s siliconization treatment creates a barrier effect and improves hydrophobic properties for all glass types in vial sizes ranging from 3ml to 500ml in both clear and amber glass.

For more information, watch the video:


Siliconization 2